Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repositioning of Antiparasitic Drugs for Tumor Treatment
Yanqi Li, Zhi Zheng, Quan‐Xing Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Atovaquone and Selinexor as a Novel Combination Treatment Option in Acute Myeloid Leukemia
Stefanie Weiß, Bernhard Zdársky, Agnieszka Witalisz‐Siepracka, et al.
Cancer Letters (2025), pp. 217501-217501
Closed Access
Inside PD-1/PD-L1,2 with their inhibitors
Nicolas Boisgerault, Philìppe Bertrand
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115465-115465
Open Access | Times Cited: 12
A novel enemy of cancer: recent investigations into protozoan anti-tumor properties
Zhi Zheng, Lu Xiao, Dong Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 3
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Juan Bautista De Sanctis, Jaime Charris, Zuleyma Blanco, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 10, pp. 1122-1144
Closed Access | Times Cited: 18
Recent advances of ferroptosis in tumor: From biological function to clinical application
Shunfeng Hu, Yurou Chu, Xiangxiang Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115419-115419
Open Access | Times Cited: 9
Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against Schistosoma-Associated Bladder Cancer Targeting Protein Signaling: Computational Drug Repositioning Approach
Arif Jamal Siddiqui, Mohammad Faheem Khan, Walid Sabri Hamadou, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1058-1058
Open Access | Times Cited: 20
Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy
Stella Newell, Pauline J. van der Watt, Virna D. Leaner
IUBMB Life (2023) Vol. 76, Iss. 1, pp. 4-25
Open Access | Times Cited: 7
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 11
Plant sesquiterpene lactones
Olivia Agatha, Daniela Mutwil‐Anderwald, Jhing Yein Tan, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1914
Closed Access | Times Cited: 1
Bioactive Microbial Metabolites in Cancer Therapeutics: Mining, Repurposing, and Their Molecular Targets
Subhaswaraj Pattnaik, Madangchanok Imchen, Ranjith Kumavath, et al.
Current Microbiology (2022) Vol. 79, Iss. 10
Closed Access | Times Cited: 8
Polyaromatic Bis(indolyl)methane Derivatives with Antiproliferative and Antiparasitic Activity
Raquel C. R. Gonçalves, Pablo Peñalver, Susana P. G. Costa, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7728-7728
Open Access | Times Cited: 4
Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway
Angela Lincy Prem Antony Samy, Mohamed Ali Hussein, Gnanasekar Munirathinam
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 9085-9104
Closed Access | Times Cited: 3
Plasmodium Circumsporozoite Protein Enhances the Efficacy of Gefitinib in Lung Adenocarcinoma Cells by Inhibiting Autophagy via Proteasomal Degradation of LC3B
Lu Xiao, Jiao Zhang, Yanqi Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
Glioblastoma as a Novel Drug Repositioning Target: Updated State
Hamed Hosseinalizadeh, Ammar Ebrahimi, Ahmad Tavakoli, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1253-1264
Closed Access | Times Cited: 2
The cytotoxic and antitumoral effects of Remdesivir, an antiviral RdRp inhibitor, on different cancer cells in vitro
Işıl Ezgi Eryılmaz, Ceyda Colakoglu Bergel, Ünal Egelí, et al.
Molecular & Cellular Toxicology (2023) Vol. 20, Iss. 3, pp. 649-660
Closed Access | Times Cited: 2
Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy
Weinan Zhang, Zhiqiang He, Fucheng Liang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 18, pp. 16763-16778
Closed Access | Times Cited: 2
CWHM-1008 Induces Apoptosis and Protective Autophagy through the Akt/mTOR Axis in LUAD Cells
Jiao Zhang, Manyuan Li, Xiao Lu, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 5
Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes
H. Matsuo, Aina Inagami, Yuri Ito, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy
Shreyas Gaikwad, Sanjay Srivastava
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 3145-3162
Closed Access
Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and Apoptosis
Miguel Hernández‐Cerón, Víctor Chavarria, Camilo Rı́os, et al.
Brain Sciences (2023) Vol. 13, Iss. 6, pp. 869-869
Open Access | Times Cited: 1
Artemether-loaded polymeric lipid-core nanocapsules reduce cell viability and alter the antioxidant status of U-87 MG cells
Jader Pires, Suéllen Alves Costa, Karoline Paiva da Silva, et al.
Pharmaceutical Development and Technology (2022) Vol. 27, Iss. 8, pp. 892-903
Closed Access | Times Cited: 2
Magic bullets, magic shields, and antimicrobials in between
Praveen Prathapan
Pharmaceutical Science Advances (2022) Vol. 1, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 2
Low-Dose Albendazole Inhibits Epithelial-Mesenchymal Transition of Melanoma Cells by Enhancing Phosphorylated GSK-3β/Tyr216 Accumulation
Zhiqiang He, Shun� Lei, Fucheng Liang, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 2
Repurposing of antiparasitic drugs against the NS2B-NS3 protease of the Zika virus
Shashank Pant, N. R. Jena
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10101-10113
Open Access
Re‐examining the evidence that ivermectin induces a melanoma‐like state in Xenopus embryos
A. S. Hutchison, Chiedza Sibanda, M. J. Hulme, et al.
BioEssays (2023) Vol. 46, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top